Cathy A. Petti, M.D., is a health technology executive and the founder and CEO of MoDx, a medical knowledge domain platform. She also serves as a practicing physician in infectious diseases.
Dr. Petti has served in a number of senior executive roles at the intersection of health and technology. As the global head at Novartis Diagnostics, she was responsible for expanding global markets for their core products and building R&D teams for three de novo franchises. As chief health officer at Ancestry, Dr. Petti built its direct-to-consumer health genetic testing portfolio and served on executive team that led to private equity investments at enterprise value of $2.6 billion. She led ARUP Infectious Diseases Laboratory, one of the country’s largest infectious diseases laboratories and pioneered research in DNA sequencing.
Dr. Petti shares her expertise and leadership with several global non-profit organizations and regulatory agencies, including having chaired committees for the Clinical and Laboratory Standards Institute, as well as serving as program lead for Infectious Diseases Society of America and advising the FDA Microbiology Device Committee.
Previously, Dr. Petti was a Governor Appointee and member of the Board of Directors for Utah’s Science, Technology and Research (USTAR) Initiative. Committed to underserved populations, she received the College of American Pathologists’ Humanitarian Award for her work in providing diagnostic testing in sub- Saharan Africa, was awarded the 2015 ASMIUSSTF Indo-US Professorship in Microbiology, and served as 2019 Visiting Professor to Infectious Diseases Institute, Kampala, Uganda.